Role of Research & Development in Market Expansion
R&D investment is a cornerstone of the Avian Influenza Vaccine Market. Major veterinary pharmaceutical companies are dedicating resources to develop vaccines that cover multiple virus subtypes, aiming to reduce the frequency of updates. Genetic sequencing of circulating strains allows for precise antigen selection, while adjuvant innovation improves immune response. Partnerships between academia, industry, and government health agencies are accelerating the pace of discovery. With emerging threats such as H5N8 and H7N9, R&D’s role is expanding from reactive measures to proactive, long-term prevention strategies that could redefine market resilience.
2 Views